Palatin Technologies Inc

Biotech Stocks Healthcare Stocks

$19.73

+0.26 (+1.34%)

As of May 16, 2:25 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target -32.7% upside

Low Target $11.80

Average Target $13.27

High Target $20.48

Current Price $19.73

Current
$19.73

Target
$13.27

$11.80 $13.27 avg $20.48

Scenario Analysis

Bear Case

$11.80

-40.2%

Low target

Base Case

$13.27

-32.7%

Avg target

Bull Case

$20.48

+3.8%

High target

Risk/Reward

0.1x

Unfavorable

Price in Context

52-Week High

$31.00

-36.4% from high

52-Week Low

$4.50

+338.4% from low

Target vs 52W High

$13.27

-57.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%